Paul R. Sleath

4.2k total citations · 3 hit papers
22 papers, 3.5k citations indexed

About

Paul R. Sleath is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Paul R. Sleath has authored 22 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Paul R. Sleath's work include Pharmacogenetics and Drug Metabolism (4 papers), Research on Leishmaniasis Studies (4 papers) and Herpesvirus Infections and Treatments (4 papers). Paul R. Sleath is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Research on Leishmaniasis Studies (4 papers) and Herpesvirus Infections and Treatments (4 papers). Paul R. Sleath collaborates with scholars based in United States, Brazil and Canada. Paul R. Sleath's co-authors include Roy A. Black, С. Kronheim, Kenneth H. Grabstein, David J. Pickup, Guy S. Salvesen, Caroline A. Ray, Nancy Hosken, Florian Kern, Louis J. Picker and Jay A. Nelson and has published in prestigious journals such as Nature, Cell and Journal of the American Chemical Society.

In The Last Decade

Paul R. Sleath

22 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Broadly targeted human cytomegalovirus-specific CD4 + and CD8 + T cells dominate the memory compartments of exposed subjects

2005 1.0k citations Andrew Sylwester, John B. Edgar et al. The Journal of Experimental Medicine profile →
Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme

1992 836 citations Caroline A. Ray, Roy A. Black et al. Cell profile →
Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

1994 524 citations Kendall M. Mohler, Paul R. Sleath et al. Nature profile →

Peers

Countries citing papers authored by Paul R. Sleath

Since Specialization

Citations

This map shows the geographic impact of Paul R. Sleath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul R. Sleath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul R. Sleath more than expected).

Fields of papers citing papers by Paul R. Sleath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul R. Sleath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul R. Sleath. The network helps show where Paul R. Sleath may publish in the future.

Co-authorship network of co-authors of Paul R. Sleath

This figure shows the co-authorship network connecting the top 25 collaborators of Paul R. Sleath. A scholar is included among the top collaborators of Paul R. Sleath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul R. Sleath. Paul R. Sleath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancer. 2006 ·PubMed ·Yoshihiro Watanabe, (unknown), Mark Elliott, Heather Secrist, Takao Tanaka, Masaaki Kawahara, Akihide Matsumura, Shigeto Hosoe, Mitsumasa Ogawara, Masaji Okada, (unknown), Paul R. Sleath, Tongtong Wang, Robert Henderson	9
2	Diversity of the CD8⁺T-Cell Response to Herpes Simplex Virus Type 2 Proteins among Persons with Genital Herpes 2006 ·Journal of Virology ·Nancy Hosken, Patrick O. McGowan, Amalia S. Meier, David M. Koelle, Paul R. Sleath, Felecia Wagener, Mark Elliott, (unknown), Christine M. Posavad, Lawrence Corey	91
3	Broadly targeted human cytomegalovirus-specific CD4 + and CD8 + T cells dominate the memory compartments of exposed subjects breakdown → 2005 ·The Journal of Experimental Medicine ·Andrew Sylwester, (unknown), John B. Edgar, (unknown), (unknown), Franziska Ruchti, Paul R. Sleath, Kenneth H. Grabstein, Nancy Hosken, Florian Kern, Jay A. Nelson, Louis J. Picker	1040
4	T Cell Recognition of HCMV: Pan-Genome Analysis of Immunogenic Open-Reading Frames. 2004 ·Blood ·Louis J. Picker, Andrew Sylwester, (unknown), (unknown), (unknown), John B. Edgar, Florian Kern, Paul R. Sleath, Kenneth H. Grabstein, Jay A. Nelson, Nancy Hosken	2
5	Serum antibodies to lipophilin B detected in late stage breast cancer patients. 2003 ·PubMed ·Darrick Carter, Davin C. Dillon, Lisa D. Reynolds, Marc W. Retter, Gary R. Fanger, David A Molesh, Paul R. Sleath, Patricia D. McNeill, Thomas S. Vedvick, Steven G. Reed, David H. Persing, Raymond L. Houghton	17
6	Identification of Babesia microti‐specific immunodominant epitopes and development of a peptide EIA for detection of antibodies in serum 2002 ·Transfusion ·Raymond L. Houghton, Mary J. Homer, Lisa D. Reynolds, Paul R. Sleath, Michael J. Lodes, Victor P. Berardi, David A. Leiby, David H. Persing	24
7	Potent Stimulation of the Innate Immune System by aLeishmania brasiliensisRecombinant Protein 2001 ·Infection and Immunity ·Monamaris Marques Borges, Antonio Campos‐Neto, Paul R. Sleath, (unknown), Philip Morrissey, Yasir A. W. Skeiky, Steven G. Reed	36
8	Multiepitope Synthetic Peptide and Recombinant Protein for the Detection of Antibodies toTrypanosoma cruziin Patients with Treated or Untreated Chagas' Disease 2000 ·The Journal of Infectious Diseases ·Raymond L. Houghton, Darin R. Benson, Lisa D. Reynolds, Patricia D. McNeill, Paul R. Sleath, Michael J. Lodes, Yasir A. W. Skeiky, Roberto Badaró, Antoniana U. Krettli, Steven G. Reed	36
9	A Multi‐Epitope Synthetic Peptide and Recombinant Protein for the Detection of Antibodies toTrypanosoma cruziin Radioimmunoprecipitation‐Confirmed and Consensus‐Positive Sera 1999 ·The Journal of Infectious Diseases ·Raymond L. Houghton, Darin R. Benson, Lisa D. Reynolds, Patricia D. McNeill, Paul R. Sleath, Michael J. Lodes, Yasir A. W. Skeiky, David A. Leiby, Roberto Badaró, Steven G. Reed	66
10	Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine. 1999 ·PubMed ·Mary L. Disis, Kenneth H. Grabstein, Paul R. Sleath, Martin A. Cheever	272
11	Evaluation of a recombinant protein(rTc24) and synthetic peptides in anti-Trypanosoma cruzi positive samples from blood bank donors in chagasic endemic areas of ecuador. 1999 ·Japanese Journal of Tropical Medicine and Hygiene ·Ángel Guevara, (unknown), Raymond L. Houghton, Lisa D. Reynolds, Paul R. Sleath, Darin R. Benson, Ali Ouaissi, Ronald H. Guderian	1
12	The K Protein Domain That Recruits the Interleukin 1-responsive K Protein Kinase Lies Adjacent to a Cluster of c-Src and Vav SH3-binding Sites 1995 ·Journal of Biological Chemistry ·Isabelle Van Seuningen, Jerzy Ostrowski, Xosé R. Bustelo, Paul R. Sleath, Karol Bomsztyk	101
13	Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing breakdown → 1994 ·Nature ·Kendall M. Mohler, Paul R. Sleath, Jeffrey N. Fitzner, Douglas Pat Cerretti, Mark R. Alderson, S.S. Kerwar, (unknown), (unknown), (unknown), (unknown), С. Kronheim, (unknown), Mary Gerhart, Carl J. Kozlosky, Carl J. March, Roy A. Black	524
14	Structural and Functional Characterization of the Interleukin-8 Receptors 1993 ·Advances in experimental medicine and biology ·M P Beckmann, Richard B. Gayle, Douglas Pat Cerretti, Carl J. March, (unknown), Paul R. Sleath	3
15	Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme breakdown → 1992 ·Cell ·Caroline A. Ray, Roy A. Black, С. Kronheim, (unknown), Paul R. Sleath, Guy S. Salvesen, David J. Pickup	836
16	Activation of interleukin‐ 1β by a co‐induced protease 1989 ·FEBS Letters ·Roy A. Black, С. Kronheim, Paul R. Sleath	211
17	Synthesis of 7,9-didecarboxymethoxatin (4,5-dihydro-4,5-dioxo-1H-pyrrolo[2,3-f]quinoline-2-carboxylic acid) and comparison of its chemical properties with those of methoxatin and analogous o-quinones. Model studies directed toward the action of PQQ requiring bacterial oxidoreductases and mammalian plasma amine oxidase 1985 ·Journal of the American Chemical Society ·Paul R. Sleath, (unknown), Gert Eberlein, Thomas C. Bruice	70
18	Model systems for cytochrome P450 dependent mono-oxygenases. Part 3. The stereochemistry of hydroxylation of cis- and trans-decahydronaphthalene by chemical models for cytochrome P450 dependent mono-oxygenases 1983 ·Journal of the Chemical Society Perkin Transactions 2 ·John R. Lindsay Smith, Paul R. Sleath	12
19	Model systems for cytochrome P450 dependent mono-oxygenases. Part 2. Kinetic isotope effects for the oxidative demethylation of anisole and [Me-2H3]anisole by cytochrome P450 dependent mono-oxygenases and model systems 1983 ·Journal of the Chemical Society Perkin Transactions 2 ·John R. Lindsay Smith, Paul R. Sleath	25
20	Magnitude of the kinetic isotope effect for the oxidative demethylation of anisole and [Me-2H3]anisole: a new and simple criterion for assessing model systems for cytochrome P450 dependent mono-oxygenases 1982 ·Journal of the Chemical Society Chemical Communications ·John R. Lindsay Smith, (unknown), Paul R. Sleath	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact